ZIM names Chen Lichtenstein CEO effective July 1, 2026 after Eli Glickman resigns; see shareholder approval details and ...

A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using ...

Today, Sikiric and his team describe BPC-157 as an all-purpose healing compound. Laboratory experiments with animals and cell cultures, they write, suggest the peptide may treat everything from muscle ...

Key Points Interested in Veeva Systems Inc.? Here are five stocks we like better. Veeva Systems said it had a strong first ...

Chen Lichtenstein will succeed Eli Glickman as ZIM CEO, bringing leadership experience from Syngenta, ADAMA and global ...

Teva's transformation is gaining momentum.

AHZANTIVE® (aflibercept) is an EMA-approved biosimilar to Eylea® (aflibercept) with demonstrated similarity in efficacy, safety and ...

Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the resubmission to ...

Biotech is producing scientific breakthroughs that once seemed impossible. But according to longtime industry executive Jeremy Levin, the institutions ...

Hikma Pharmaceuticals USA is adding 300 jobs at its suburban Cleveland plant in Bedford and 50 jobs at its Columbus ...